Lumos Pharma, Inc.

Industry

  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Large Molecule

Other Names/Subsidiaries

  • BioProtection Systems
  • BlueLink Pharmaceuticals
  • Lumos Pharma Sub
  • Newlinks Genetics
See more in Biomedtracker

Latest on Lumos Pharma, Inc.

Scrip

Finance Watch: Septerna Raises $288m In Public Market Debut

 
• By Mandy Jackson

The tally of biopharmaceutical companies that have gone public in the US in 2024 has now surpassed not only last year’s total but the total from 2022 now that Septerna Inc. has launched its IPO, gross

Pink Sheet

Rare Pediatric Disease Voucher Program Gains Temporary Extension From House Committee

 
• By Derrick Gingery

The rare pediatric disease priority review voucher would be saved under pending House legislation, but advocates would have to fight to keep it alive again in 2024. House Energy and Commerce Committee

Pink Sheet

Rare Pediatric Priority Review Voucher Program Seems Headed For Short-Term Renewal

 
• By Derrick Gingery

Reauthorization of the rare pediatric disease priority review voucher program does not appear threatened by the House Energy and Commerce Committee, but the fact that questions about its value continu

Scrip

Merck Warned Of Q2 Slump, But How Far Did Revenue Fall?

 
• By Mandy Jackson

Merck & Co., Inc. was the first big pharma company during the first quarter earnings season in late April/early May to admit that the COVID-19 pandemic was going to have an impact on product sales an